Found 2 articles for: "IL-13"
Real-World Effectiveness of Lebrikizumab for the Prurigo Nodularis–Like Phenotype of Atopic Dermatitis: A One-Year Retrospective Study
February 2026 | Volume 25 | Issue 2 | Editorials | e38 | Copyright © February 2026
Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade
October 2023 | Volume 22 | Issue 10 | Editorials | 1007 | Copyright © October 2023
In 2017, dupilumab became the first FDA approved systemic therapy for atopic dermatitis. Since its approval, extensive clinical experience and continued research have revealed a number of unexpected e...
Read More
